News
Advertisement
Advertisement
Delivering the Drs. Henry and Frederick Sutro Memorial Lecture, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation.
Advertisement
The Glaucoma Symposium offers ophthalmology and optometry professionals an opportunity to sharpen their knowledge about glaucoma.
Advertisement
Key opinion leaders review approaches used to improve outcomes in patients with open-angle glaucoma.
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
FDA feedback supports Azura’s Ophthalmic's planned NDA for AZR-MD-001 in MGD
3
Neurotrophic keratitis outcomes improve with early, stage-based care
4
Alcon raises offer in amended deal to acquire STAAR Surgical
5
.png "Optometry Times"){kind=logo}
